Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 040298
Company: MYLAN
Company: MYLAN
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| EXTENDED PHENYTOIN SODIUM | PHENYTOIN SODIUM | 100MG EXTENDED | CAPSULE;ORAL | Discontinued | None | No | No |
| PHENYTEK | PHENYTOIN SODIUM | 200MG EXTENDED | CAPSULE;ORAL | Prescription | AB | No | No |
| PHENYTEK | PHENYTOIN SODIUM | 300MG EXTENDED | CAPSULE;ORAL | Prescription | AB | No | Yes |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 12/28/1998 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/40298lbl.pdf |